The Impact of Ischemic Heart Disease on Symptoms, Health Status, and Exacerbations in Patients With COPD

被引:82
作者
Patel, Anant R. C. [1 ]
Donaldson, Gavin C. [1 ]
Mackay, Alex J. [1 ]
Wedzicha, Jadwiga A. [1 ]
Hurst, John R. [1 ]
机构
[1] UCL, Sch Med, Acad Unit Resp Med, London NW3 2PF, England
基金
英国医学研究理事会;
关键词
OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION; MYOCARDIAL-INFARCTION; INFLAMMATORY MARKERS; INCREASED RISK; MORTALITY; COMORBIDITIES; PREVALENCE; EVENTS; STROKE;
D O I
10.1378/chest.11-0853
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Comorbid ischemic heart disease (IHD) is a common and important cause of morbidity and mortality in patients with COPD. The impact of IHD on COPD in terms of a patient's health status, exercise capacity, and symptoms is not well understood. Methods: We analyzed stable-state data of 386 patients from the London COPD cohort between 1995 and 2009 and prospectively collected exacerbation data in those who had completed symptom diaries for >= 1 year. Results: Sixty-four patients (16.6%) with IHD had significantly worse health status as measured by the St. George Respiratory Questionnaire (56.9 +/- 18.5 vs 49.1 +/- 19.0, P = .003), and a larger proportion of this group reported more severe breathlessness in the stable state, with a Medical Research Council dyspnea score of >= 4 (50.9% vs 35.1%, P = .029). In subsets of the sample, stable patients with COPD with IHD had a higher median (interquartile range [IQR]) serum N-terminal pro-brain natriuretic peptide concentration than those without IHD (38 [15, 107] pg/mL vs 12 [6, 21] pg/mL, P = .004) and a lower exercise capacity (6-min walk distance, 225 +/- 89 m vs 317 +/- 85 m; P = .002). COPD exacerbations were not more frequent in patients with IHD (median, 1.95 [IQR, 1.20, 3.12] vs 1.86 (IQR, 0.75, 3.96) per year; P = .294), but the median symptom recovery time was 5 days longer (17.0 [IQR, 9.8, 24.2] vs 12.0 [IQR, 8.0, 18.0]; P = .009), resulting in significantly more days per year reporting exacerbation symptoms (median, 35.4 [IQR, 13.4, 60.7] vs 22.2 [IQR, 5.7, 42.6]; P = .028). These findings were replicated in multivariate analyses allowing for age, sex, FEV1 and exacerbation frequency where applicable. Conclusions: Comorbid HID is associated with worse health status, lower exercise capacity, and more dyspnea in stable patients with COPD as well as with longer exacerbations but not with an increased exacerbation frequency. CHEST 2012; 141(4):851-857
引用
收藏
页码:851 / 857
页数:7
相关论文
共 42 条
[1]   Characterisation of COPD heterogeneity in the ECLIPSE cohort [J].
Agusti, Alvar ;
Calverley, Peter M. A. ;
Celli, Bartolome ;
Coxson, Harvey O. ;
Edwards, Lisa D. ;
Lomas, David A. ;
MacNee, William ;
Miller, Bruce E. ;
Rennard, Steve ;
Silverman, Edwin K. ;
Tal-Singer, Ruth ;
Wouters, Emiel ;
Yates, Julie C. ;
Vestbo, Jorgen .
RESPIRATORY RESEARCH, 2010, 11
[2]   Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease [J].
Bestall, JC ;
Paul, EA ;
Garrod, R ;
Garnham, R ;
Jones, PW ;
Wedzicha, JA .
THORAX, 1999, 54 (07) :581-586
[3]   Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations [J].
Bhowmik, A ;
Seemungal, TAR ;
Sapsford, RJ ;
Wedzicha, JA .
THORAX, 2000, 55 (02) :114-120
[4]   Underdiagnosis of myocardial infarction in COPD - Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation [J].
Brekke, Pal H. ;
Omland, Torbjorn ;
Smith, Pal ;
Soyseth, Vidar .
RESPIRATORY MEDICINE, 2008, 102 (09) :1243-1247
[5]   Fatal adverse drug events: the paradox of drug treatment [J].
Buajordet, I ;
Ebbesen, J ;
Erikssen, J ;
Brors, O ;
Hilberg, T .
JOURNAL OF INTERNAL MEDICINE, 2001, 250 (04) :327-341
[6]   VALIDATION OF A COMBINED COMORBIDITY INDEX [J].
CHARLSON, M ;
SZATROWSKI, TP ;
PETERSON, J ;
GOLD, J .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (11) :1245-1251
[7]   ATS statement: Guidelines for the six-minute walk test [J].
Crapo, RO ;
Casaburi, R ;
Coates, AL ;
Enright, PL ;
MacIntyre, NR ;
McKay, RT ;
Johnson, D ;
Wanger, JS ;
Zeballos, RJ ;
Bittner, V ;
Mottram, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) :111-117
[8]   Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation [J].
Crisafulli, E. ;
Costi, S. ;
Luppi, F. ;
Cirelli, G. ;
Cilione, C. ;
Coletti, O. ;
Fabbri, L. M. ;
Clini, E. M. .
THORAX, 2008, 63 (06) :487-492
[9]   Increased Risk of Myocardial Infarction and Stroke Following Exacerbation of COPD [J].
Donaldson, Gavin C. ;
Hurst, John R. ;
Smith, Christopher J. ;
Hubbard, Richard B. ;
Wedzicha, Jadwiga A. .
CHEST, 2010, 137 (05) :1091-1097
[10]   COPD exacerbations 1: Epidemiology [J].
Donaldson, GC ;
Wedzicha, JA .
THORAX, 2006, 61 (02) :164-168